ALACHUA, Fla., March 5, 2013 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (OTCBB:AXGN), a leader in the science and commercialization of surgical solutions for peripheral nerve repair, announced today the appointment of Shawn McCarrey to the position of Senior Vice President of Sales, effective immediately. In this role, Mr. McCarrey will participate in the implementation of the Company's strategic growth initiatives and will lead AxoGen's sales organization in the United States.
"We are now transitioning into the next phase of the Company's growth, moving from early adopters to broad usage in surgical peripheral nerve repair," said Karen Zaderej, Chief Executive Officer of AxoGen. "Shawn's many years of experience and strong track record of success growing sales of early stage medical technologies will enhance AxoGen's capabilities and accelerate adoption. With a strong management team in place and the addition of resources from our recent PDL funding, we are well positioned to drive growth in the peripheral nerve repair market."
Mr. McCarrey brings to AxoGen more than 15 years of experience as a national medical device sales executive. He most recently served as Executive Vice President of North American Cardiovascular Sales at Bayer Interventional/MEDRAD Interventional. From 1998 through 2009, Mr. McCarrey was rapidly promoted through the executive ranks at Possis Medical, an early commercial stage cardio- and peripheral-vascular company ultimately acquired by MEDRAD Interventional, culminating with his appointment as EVP of Worldwide Sales & Marketing. Earlier in his career, Mr. McCarrey served in sales and sales leadership roles in the Davol and USCI divisions of C.R. Bard.
About AxoGen, Inc.
AxoGen (OTCBB:AXGN) is a regenerative medicine company dedicated to advancing the science and commercialization of peripheral nerve repair solutions. The Company's innovative approach to regenerative medicine has resulted in first-in-class products that will define their product categories. AxoGen's products offer a full suite of surgical nerve reconstruction solutions including Avance® Nerve Graft, the only commercially available processed nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa ECM coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa EMC product used to wrap and protect injured peripheral nerves and reinforce coaptation sites while preventing soft tissue attachments. For more information, visit our website at http://www.axogeninc.com.
AxoGen is the parent of its wholly owned operating subsidiary, AxoGen Corporation. AxoGen's principal executive office and operations are located in Alachua, FL.
To receive email alerts directly from AxoGen, please click here http://www.axogeninc.com/emailalerts.html.
This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2013/3/prweb10497195.htm
CONTACT: AxoGen, Inc. Greg Freitag, Chief Financial Officer InvestorRelations@AxoGenInc.com 386.462.6852
|Move, Inc. Appoints Ray Picard as Executive Vice President of Sales (2013/4/18)|
|Columbia Sportswear Company Announces Appointment of Shawn Cox as Senior Vice President of Retail (2013/4/29)|
|Digi Appoints Senior Vice President of Sales (2013/1/30)|
|MAKO Surgical Corp. Announces Appointment of Christopher R. Marrus as Senior Vice President of Sales (2013/2/21)|
|Coeur Appoints Joe Phillips to Senior Vice President and Chief Development Officer and William N. Holder to Vice President of Health and Safety (2013/3/21)|
|Allied World Appoints Sarah Doran to Senior Vice President, Investor Relations and Treasurer (2013/4/11)|
|Saks Fifth Avenue Appoints John Cruz as Senior Vice President and Director of the New York Flagship Store (2013/3/25)|
|Natus Appoints Jonathan Kennedy as Senior Vice President and Chief Financial Officer (2013/3/11)|
|Qualcomm Strengthens Silicon Valley Presence with Appointment of Laurie Yoler, Senior Vice President of Business Development (2013/3/6)|
|Dynavax Appoints David Novack as Senior Vice President, Operations and Quality (2013/3/21)|
|AxoGen Inc||View axgn Stock Quote|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)|
|P||Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)|
|P||Morningstar Stock Analyst Reports (full research on 2,000 stocks)|
|P||Morningstar Stock and Fund Stewardship Grades|
|P||Portfolio Manager (advanced with 10 x-ray analyses, including guidance)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.